-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Silence Therapeutics plc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2022 to Q3 2025.
- Silence Therapeutics plc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 142M shares, a 0.36% increase year-over-year.
- Silence Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 139M shares, a 24.7% increase from 2023.
- Silence Therapeutics plc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 111M shares, a 15.2% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)